Headline
The latest stories from AHA Today.
The Internal Revenue Service July 6 issued a clarification on the tax treatment of funds received from the Provider Relief Fund.
Americans overwhelmingly support hospitals and further aid as front-line health care providers fight to defeat COVID-19, regardless of party affiliation, according to a poll released by the Coalition to Protect America’s Health Care.
All hospitals regardless of ownership provide a comprehensive range of benefits and essential services to their communities.
AHA voiced support for the Critical Access Hospital Expansion Act (H.R. 6693), legislation that would reopen the “necessary provider” designation to eligible rural hospitals.
To aid hospitals and health systems in identifying health disparity gaps, Elisa Arespacochaga, vice president of the AHA Physician Alliance and interim executive lead of AHA's Institute for Diversity and Health Equity, highlights new race, ethnicity and language (REaL) data resources and tools to…
Through its 100 Million Mask Challenge AHA partnered with Microsoft, UPS, Kaiser Permanente, Goodwill, Merit Solutions and consulting firm Kearney to create HealthEquip, a smart app to connect hospitals treating COVID-19 patients with donations of personal protective equipment.
The Food and Drug Administration added dexamethasone sodium phosphate to its lists for temporary compounding by outsourcing facilities and pharmacy compounders during the COVID-19 emergency.
Two new case studies affirm that cloth face coverings “are a critical tool in the fight against COVID-19 that could reduce the spread of the disease, particularly when used universally within communities,” the Centers for Disease Control and Prevention said.
The Queen’s Health Systems in Honolulu, Hawaii, shared how COVID-19 has caused significant financial challenges for the organization and why Congress needs to provide additional support to hospitals and health systems.
The first human study evaluating an mRNA COVID-19 vaccine made by Moderna Inc. produced neutralizing antibodies in healthy adults, who generally tolerated the vaccine well, the National Institutes of Health reports.